Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 100 participants.

Also called NCT06782646

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06782646
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT06782646. Randomized; double masking; primary purpose prevention. Start 2024-08-01 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine
Condition
Hyperlipidemia
Intervention (Drug)
Berberine
Intervention (Drug)
Placebo
Lead sponsor
The University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct06782646
Content hash
14febb0ed14c22a4dc4084e06d0e450079039f35d6dcc015eb136887ebdec34b